The trajectory of companies tied to iconic drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the loss of exclusivity in key territories has introduced significant volatility. Investors are now grappling with the effect of generic c